Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Shortage Notification Mandate May Not Extend To Biologics

Dec 24 2012

• By Derrick Gingery

Related Content

FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

Dec 19 2011

Genzyme Plant Cleanup Brings Temporary Halt To Fabrazyme, Cerezyme Production

Jun 16 2009

Obama's Drug Shortage Efforts Focus On Personnel, Persuasion

Oct 31 2011

FDA And Generic Drug Quality: Turning Point, Or Precipice?

Oct 08 2012

Biosimilar Meeting Requests Increase, But FDA Cancels Some For Lack Of Data

Dec 12 2012

PDUFA’s ‘Huge’ GMP Change Will Tie Adulteration To Quality System

Jun 11 2012

Shire Withdraws <em>Replagal</em> BLA Rather Than Conduct Lengthy Trials – <em>Updated</em>

Mar 15 2012

Differentiation Will Be Key Challenge For Shire's Gaucher Disease Drug Vpriv

Mar 08 2010

Related Companies

Sanofi Genzyme

Sanofi

Takeda Pharmaceutical Co. Ltd.

Protalix BioTherapeutics, Inc.

Additional Topics

United States Legislation Quality BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window